Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options
Prostate cancer (PCa) is the second most commonly diagnosed malignant tumor and the fifth leading cause of cancer death in men in the world. The most common types of tumors are adenocarcinomas. Prostate cancer is a slow-growing cancer. The incidence increases with age. Evaluation of proinflammatory...
Saved in:
Main Authors: | Marlena Janiczek, Łukasz Szylberg, Paulina Antosik, Anna Kasperska, Andrzej Marszałek |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/4910595 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IL-17A and Th17 Cells in Lung Inflammation: An Update on the Role of Th17 Cell Differentiation and IL-17R Signaling in Host Defense against Infection
by: Hsing-Chuan Tsai, et al.
Published: (2013-01-01) -
Parasite-Specific IL-17-Type Cytokine Responses and Soluble IL-17 Receptor Levels in Alveolar Echinococcosis Patients
by: Christian J. Lechner, et al.
Published: (2012-01-01) -
Potential Involvement of IL-17F in Asthma
by: Kyoko Ota, et al.
Published: (2014-01-01) -
Evolutionary Insights into IL17A in Lagomorphs
by: Fabiana Neves, et al.
Published: (2015-01-01) -
Salivary IL-17A, IL-17F, and TNF-α Are Associated with Disease Advancement in Patients with Oral and Oropharyngeal Cancer
by: Kinga Zielińska, et al.
Published: (2020-01-01)